PSNL: Amendment: SEC Form SC 13E3/A filed by Personalis Inc.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for PSNL
Across the 30 sessions after earlier PSNL headlines, the stock closed higher 14 times and lower 15 times, with a median move of 2.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | PSNL | SPY |
|---|---|---|---|
| Oct 20, 2026 | Personalis Brings Resistance Mutation Tracking to NeXT Personal® MRD Test | +0.4% | +0.3% |
| Oct 6, 2026 | Personalis downgraded by BTIG Research | -2.3% | +0.5% |
| Aug 24, 2026 | Personalis downgraded by Craig Hallum with a new price target | -7.2% | -0.3% |
| Aug 5, 2026 | Personalis Reports Second Quarter Results and Recent Highlights | +0.0% | -0.2% |
| Jul 14, 2026 | Personalis Accelerates Global Expansion with UKCA Marking for NeXT Personal®, Expanding MRD Access and Biopharma Support in Great Britain | -0.1% | +0.4% |
| Jun 9, 2026 | Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits | -2.9% | -0.3% |
Quantisnow market dataNASDAQ
PSNL
Personalis Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical Specialities
- Listed since
- 2019
Get push alerts for PSNL
Full PSNL profile on Quantisnow Follow PSNL and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time